| WDTC | Well Differentiated Thyroid Cancer |
| PDTC | Poorly Differentiated Thyroid Cancer |
| ATC | Anaplastic Thyroid Cancer |
| RET | Rearranged During Transfection |
| PTC | Papillary Thyroid Cancer |
| FTC | Follicular Thyroid cancer |
| MAPK | Mitogen-Activated Protein Kinase |
| PPARc | Peroxisome Proliferator-Activated Receptor C |
| PAX8 | Paired Box 8 |
| RAS | Rat Sarcoma |
| PI3K | Phosphatidyl-Inositol-3-Kinase |
| PTEN | Phosphatase and Tensin Homolog |
| CTNNB1 | Catenin beta 1 |
| TAD | Transactivation Domain |
| DBD | DNA Binding Domain |
| OD | Oligomerization Domain |
| PRD | Prolin-Rich Sequence recognition Domain |
| SAMD | Steril Alpha Motif Domain |
| TID | Transactivation Inhibitory Domain |
| HMGA | High Mobility Group A |
| PATZ1 | POZ7BTB and AT Hook containing Zinc-finger Protein |
| ABRO1 | Abraxas Brother 1 |
| PBF | PTTG1-Binding Factor |
| MDM | Murine Double Minute |
| HUWE1 | HECT, UBA, and WWE Domain-Containing Protein 1 |
| WIP1 | Wild Type p53 Induced Phosphatases 1 |
| Gal-3 | Galectin-3 |
| HIPK2 | Homeodomain Interacting Protein Kinase 2 |
| FOXE1 | Forkhead7Winged Helix-Domain Protein |
| MYH9 | Myosin-9 |
| PTCSC2 | Papillary Thyroid Cancer Susceptibility Candidate 2 |
| THBS1 | Thrombospondin 1 |
| IGFBP3 | Insulin-Like Growth Factor Binding Protein 3 |
| MKIs | Multi-Kinase Inhibitors |
| HDAC | Histone Deacetylase |
| ROCK | Rho Kinase |
| DNMT | DNA Methyltransferase |
| MEK | Mitogen-Activated protein kinase kinase |
| TDP-A | Thailandepsin A |
| PRIMA-1 | p53 Reactivation and Induction of Massive Apoptosis |
| GADD45A | Growth Arrest and DNA Damage Inducible Alpha |
| TET | Ten-Eleven Translocation |
| mTOR | Mammalian Target of Rapamycine |